Regen BioPharma Inc (RGBP) Corporate Subsidiaries
Regen BioPharma Inc (RGBP) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RGBP
CIK: 1589150
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BCRG Group
Auditor SinceSince 9/30/2024 12:00:00 AM
Lead Engagement PartnerBenjamin Chung
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-17 | 2026-06-30 | 10-Q | 0001493152-26-038576 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-13 | 2026-06-30 | NT 10-Q | 0001493152-26-037682 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-10 | 8-K | 0001493152-26-033364 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-022924 | View SEC Doc Filr Page |
| 8-K | 2026-03-04 | 2026-02-04 | 8-K | 0001493152-26-008837 | View SEC Doc Filr Page |
| 10-Q | 2026-02-13 | 2025-12-31 | 10-Q | 0001493152-26-006526 | View SEC Doc Filr Page |
| 8-K | 2026-02-02 | 2026-01-15 | 8-K | 0001493152-26-004733 | View SEC Doc Filr Page |
| 8-K | 2026-01-21 | 2026-01-19 | 8-K | 0001493152-26-002956 | View SEC Doc Filr Page |
| QUALIF | 2026-01-12 | — | QUALIF Filing | 9999999994-26-000013 | View SEC Doc Filr Page |
| 1-A POS | 2026-01-08 | — | 1-A POS Filing | 0001493152-26-000934 | View SEC Doc Filr Page |
| 10-K | 2025-12-30 | 2025-09-30 | 10-K | 0001493152-25-029526 | View SEC Doc Filr Page |
| 253G1 | 2025-12-05 | — | 253G1 | 0001493152-25-026350 | View SEC Doc Filr Page |
| QUALIF | 2025-12-03 | — | QUALIF Filing | 9999999994-25-000213 | View SEC Doc Filr Page |
| CORRESP | 2025-12-01 | — | CORRESP Filing | 0001493152-25-025510 | View SEC Doc Filr Page |
| 1-A | 2025-11-17 | — | 1-A Filing | 0001493152-25-023753 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-10-08 | 8-K | 0001493152-25-022185 | View SEC Doc Filr Page |
| 8-K | 2025-10-03 | 2025-10-02 | 8-K | 0001493152-25-016767 | View SEC Doc Filr Page |
| 8-K | 2025-09-19 | 2025-09-15 | 8-K | 0001493152-25-014182 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-09-12 | — | SCHEDULE 13G Filing | 0001213900-25-087236 | View SEC Doc Filr Page |
| 253G1 | 2025-09-08 | — | 253G1 | 0001641172-25-026822 | View SEC Doc Filr Page |
| QUALIF | 2025-09-05 | — | QUALIF Filing | 9999999994-25-000175 | View SEC Doc Filr Page |
| CORRESP | 2025-09-04 | — | CORRESP Filing | 0001641172-25-026585 | View SEC Doc Filr Page |
| UPLOAD | 2025-09-04 | — | UPLOAD Filing | 0000000000-25-009550 | View SEC Doc Filr Page |
| 1-A | 2025-08-29 | — | 1-A Filing | 0001641172-25-025977 | View SEC Doc Filr Page |
| 1-A-W | 2025-08-12 | — | 1-A-W | 0001641172-25-023226 | View SEC Doc Filr Page |